- Novel targets for the treatment of heart failure accompanied with systemic inflammatory response syndrome in experiments.
Ionov DI, Galenko Iaroshevsky PA, Sukoyan GV, Dolidze NM
- Novel therapeutic approaches for treatment of irritable bowel syndrome using the multi-herbal drug STW 5
Nieber K, Voss U, Abdel Aziz H, Weiser D, Kelber O, Michael S
- Novel Thiazolo[3,2- b ]-1,2,4-triazole-5(6 H )-ones Substituted with Ibuprofen as Potent and Safer Antiinflammatory/Analgesic Agents
Ozturk EI, Kazkayasi I, Sarigol D, Uzgoren A, Okay G, Ertan M, Tozkoparan B, Tel BC
- Novel Y2 receptor agonist has differential anorectic effects when administered via bolus injection and continuous infusion: Implications for dosing strategies
Hostomska Klara
- Nox2-derived oxidative stress and ageing-associated metabolic disorders and vascular dysfunction
S Cahill-Smith, JM Li
- NOX2 Inhibition Restores Contractility, Intracellular Calcium Handling and Reduces Arrhythmogenicity in Dystrophic Cardiomyopathy
A Treuer, R Dulce, D Gonzalez
- Nox5, cholesterol-rich microdomains and Ang II signalling in human vascular smooth muscle cells
A Anagnostopoulou, P Persson, A Montezano, R Touyz
- Nox5 is involved in angiotensin-II-induced arterial fractalkine (CX 3 CL1) expression and mononuclear cell arrest
Rius C, Piqueras L, Albertos F, Gonzalez H, Escudero P, Morcillo EJ, Sanz MJ
- Noxious-evoked changes in levels of endocannabinoids in the central nervous system
D.Richardson; D.A.Kendall; S.R.G.Beckett; D.A.Barrett & V.Chapman
- NPY-mediated inhibition of neurally evoked contraction in the dog urinary bladder and localisation of NPY receptor subtype mRNA expression
Suzanne Dowson, Sheridan Piper-Brown, Rachel McCoy & Clare Christy
